Appointment booking for Dr. Yogindra Balhara, MD is currently not available.Dr. Yogindra Balhara, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Yogindra Balhara, MD (he/him) is a Internist in Chambersburg, PA with over 19 years of experience. What is your opinion of Dr. Yogindra Balhara, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Yogindra Balhara, MD has received over $1,169 which includes payments from the following companies:
$291.65 from Sunovion Pharmaceuticals Inc.
$222.86 from Janssen Pharmaceuticals, Inc
$133.14 from sanofi-aventis U.S. LLC
$118.88 from AstraZeneca Pharmaceuticals LP
$72.14 from GlaxoSmithKline, LLC.
$48.06 from Actavis Pharma Inc
$47.19 from Smith & Nephew, Inc.
$39.97 from Novartis Pharmaceuticals Corporation
$32.95 from FOREST PHARMACEUTICALS, INC.
$31.18 from Daiichi Sankyo Inc.
$26.69 from Sanofi Pasteur Inc.
$26.01 from LILLY USA, LLC
$14.92 from Medtronic USA, Inc.
$13.89 from Allergan Inc.
$13.69 from Teva Pharmaceuticals USA, Inc.
$12.14 from Avanir Pharmaceuticals, Inc.
$12.13 from Astellas Pharma US Inc
$12.06 from ACADIA Pharmaceuticals Inc
Payments received by Dr. Yogindra Balhara, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!